EI
BMRN icon

Ethic Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Ethic Inc’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$311K Buy
+5,513
New +$321K ﹤0.01% 1026
2024
Q4 		– Sell
-6,114
Closed -$534K – 1157
2024
Q3 		$534K Buy
6,114
+1,402
+30% +$117K 0.01% 747
2024
Q2 		$388K Sell
4,712
-1,402
-23% -$117K 0.01% 830
2024
Q1 		$534K Buy
6,114
+1,182
+24% +$106K 0.01% 746
2023
Q4 		$476K Sell
4,932
-1,021
-17% -$90.3K 0.01% 748
2023
Q3 		$527K Buy
5,953
+2,765
+87% +$246K 0.02% 663
2023
Q2 		$276K Sell
3,188
-403
-11% -$37.9K 0.01% 812
2023
Q1 		$349K Buy
3,591
+495
+16% +$51.3K 0.01% 750
2022
Q4 		$320K Buy
+3,096
New +$291K 0.02% 697

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return